Acuta Capital Partners as of June 30, 2018
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 52 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 20.0 | $112M | 4.8M | 23.67 | |
| Iovance Biotherapeutics (IOVA) | 9.6 | $54M | 4.2M | 12.80 | |
| Assembly Biosciences | 9.1 | $51M | 1.3M | 39.21 | |
| Argenx Se (ARGX) | 6.7 | $38M | 453k | 82.86 | |
| Kadmon Hldgs | 6.4 | $36M | 9.1M | 3.99 | |
| Veracyte (VCYT) | 4.4 | $25M | 2.7M | 9.34 | |
| Chembio Diagnostics | 4.0 | $23M | 2.0M | 11.10 | |
| Ascendis Pharma A S (ASND) | 3.7 | $21M | 311k | 66.52 | |
| Arrowhead Pharmaceuticals (ARWR) | 3.0 | $17M | 1.2M | 13.60 | |
| IRIDEX Corporation (IRIX) | 2.5 | $14M | 2.0M | 6.96 | |
| Intec Pharma | 2.3 | $13M | 3.0M | 4.40 | |
| Zogenix | 1.9 | $11M | 238k | 44.20 | |
| Viewray (VRAYQ) | 1.8 | $10M | 1.5M | 6.92 | |
| CAS Medical Systems | 1.8 | $10M | 5.3M | 1.95 | |
| Madrigal Pharmaceuticals (MDGL) | 1.7 | $9.7M | 35k | 279.69 | |
| Catalyst Biosciences | 1.7 | $9.7M | 830k | 11.67 | |
| SPDR S&P Biotech (XBI) | 1.7 | $9.5M | 100k | 95.19 | |
| Biohaven Pharmaceutical Holding | 1.5 | $8.4M | 214k | 39.52 | |
| Sarepta Therapeutics (SRPT) | 1.4 | $7.9M | 60k | 132.18 | |
| Viking Therapeutics (VKTX) | 1.3 | $7.1M | 750k | 9.49 | |
| Regeneron Pharmaceuticals (REGN) | 1.2 | $6.9M | 20k | 345.00 | |
| iShares MSCI Emerging Markets Indx (EEM) | 1.2 | $6.5M | 150k | 43.33 | |
| Obseva Sa | 1.1 | $6.4M | 424k | 15.14 | |
| Coherus Biosciences (CHRS) | 1.0 | $5.5M | 395k | 14.00 | |
| Cutera (CUTR) | 0.8 | $4.2M | 105k | 40.30 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $4.1M | 450k | 9.20 | |
| Aerie Pharmaceuticals | 0.7 | $4.1M | 61k | 67.57 | |
| Apellis Pharmaceuticals (APLS) | 0.7 | $3.7M | 168k | 22.00 | |
| Mei Pharma | 0.6 | $3.5M | 880k | 3.94 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.5 | $3.0M | 3.0M | 1.01 | |
| Zafgen | 0.5 | $2.6M | 250k | 10.23 | |
| Fennec Pharmaceuticals (FENC) | 0.5 | $2.6M | 250k | 10.44 | |
| Acer Therapeutics | 0.4 | $2.4M | 109k | 21.60 | |
| Magenta Therapeutics | 0.4 | $2.3M | 170k | 13.50 | |
| Tesaro | 0.4 | $2.2M | 50k | 44.48 | |
| Vericel (VCEL) | 0.3 | $1.8M | 190k | 9.70 | |
| Editas Medicine (EDIT) | 0.3 | $1.8M | 50k | 35.84 | |
| Kezar Life Sciences (KZR) | 0.3 | $1.7M | 100k | 17.30 | |
| Deutsche Bank Ag-registered (DB) | 0.3 | $1.6M | 150k | 10.62 | |
| Forty Seven | 0.2 | $1.2M | 73k | 16.00 | |
| AMAG Pharmaceuticals | 0.2 | $975k | 50k | 19.50 | |
| Alimera Sciences | 0.2 | $955k | 974k | 0.98 | |
| Esperion Therapeutics (ESPR) | 0.2 | $980k | 25k | 39.20 | |
| OraSure Technologies (OSUR) | 0.1 | $824k | 50k | 16.48 | |
| STAAR Surgical Company (STAA) | 0.1 | $775k | 25k | 31.00 | |
| Viveve Med | 0.1 | $728k | 268k | 2.72 | |
| Polarityte | 0.1 | $589k | 25k | 23.56 | |
| Zynerba Pharmaceuticals | 0.1 | $487k | 50k | 9.74 | |
| Mannkind (MNKD) | 0.0 | $204k | 108k | 1.90 | |
| Rockwell Medical Technologies | 0.0 | $123k | 25k | 4.92 | |
| Transenterix | 0.0 | $109k | 25k | 4.36 | |
| Oncobiologics | 0.0 | $25k | 29k | 0.86 |
